Exelixis
EXEL
#1806
Rank
A$16.65 B
Marketcap
A$62.12
Share price
0.55%
Change (1 day)
6.59%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2024: A$0.96 Billion

According to Exelixis's latest financial reports the company's current earnings are A$2.28 Billion. In 2024 the company made an earning of A$0.96 Billion, an increase over its 2023 earnings that were of A$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2024

Annual earnings

Year Earnings Change
2024A$0.96 B164.69%
2023A$0.36 B9.89%
2022A$0.33 B-20.33%
2021A$0.41 B124.82%
2020A$0.18 B-67.14%
2019A$0.56 B-11.94%
2018A$0.64 B185.09%
2017A$0.22 B-325.82%
2016-A$99.45 Million-58.12%
2015-A$0.24 Billion-37.61%
2014-A$0.39 Billion9.75%
2013-A$0.35 Billion65.96%
2012-A$0.21 Billion-291.63%
2011A$0.10 B-195.59%
2010-A$0.12 Billion-42.17%
2009-A$0.2 Billion-18.98%
2008-A$0.25 Billion-6.99%
2007-A$0.27 Billion46.3%
2006-A$0.18 Billion33.25%
2005-A$0.14 Billion-30.92%
2004-A$0.2 Billion44.29%
2003-A$0.14 Billion12.86%
2002-A$0.12 Billion22.79%
2001-A$97.21 Million60.14%
2000-A$60.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.87 B 3,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$16.78 B 1,257.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.67 B 844.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$12.88 B 942.07%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$32.69 B 2,544.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.37 B 819.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.20 B 967.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-A$46.11 Million-103.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-A$41.13 Million-103.33%๐Ÿ‡บ๐Ÿ‡ธ USA